Daniel Adunkwah: Reimagining Safety and Choice with Autologous Blood Transfusions
Daniel Adunkwah, Doctor of Medical Laboratory Science, Laboratory Manager at Presbyterian Health Services, shared a post on LinkedIn:
“Autologous Blood Transfusion: A Significant Moment in Patient Care and Choice
Recent developments within the community of Jehovah’s Witnesses have brought renewed attention to an important medical practice, autologous blood transfusion. With increasing openness toward members receiving their own blood, this approach is becoming even more relevant in clinical care and patient centered medicine.
Autologous blood transfusion involves collecting and reinfusing a patient’s own blood, either before surgery or during a medical procedure. It is a concept that continues to bridge medical innovation with individual beliefs and healthcare preferences.
1. Why this matters now
Autologous transfusion provides an option that aligns medical treatment with personal convictions. For many patients, especially those who have previously declined donor blood, this development offers a pathway to safer surgical care while respecting deeply held beliefs.
2. Clinical significance
From a clinical perspective, autologous blood transfusion reduces the risk of transfusion transmitted infections and eliminates compatibility concerns. It is particularly useful in surgeries where significant blood loss is expected, and it supports modern strategies in patient blood management.
3. The broader healthcare insight
This moment highlights something important in medicine, the need to continually adapt care to meet patients where they are. When clinical science and patient values work together, outcomes improve and trust in healthcare grows stronger.
Autologous blood transfusion reminds us that sometimes the safest and most acceptable solution is one that comes directly from the patient themselves.
Dr. Daniel Adunkwah
Doctor of Medical Laboratory Science”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime
-
Sep 21, 2026, 13:56Alex Knapp: Emerging Technologies and Advances in Hemophilia Care
-
Sep 21, 2026, 13:51Abdalhakim Shubietah: pLAAO Fails Noninferiority to OAC in Landmark Meta-Analysis of 7 RCTs